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Aims:  
 
• To identify if baseline vitamin D status is associated with 
future glycaemic control.  
• To assess whether vitamin D status differs between two 
groups when classified by glucose control (above or below 
6.1 mmol/l: cut off point for impaired fasting glucose2).  
Methods:  
 
Following ethical approval 104 participants (female 53; male 
51) were recruited from the local community (Mid-Wales). 
Participants with varying levels of glucose control attended the 
laboratory in a fasted state on three occasions, each separated 
by 6 months. During each visit blood was drawn from an 
antecubital vein and stored for later analyses.  
 
Vitamin D status was determined (25 hydroxyvitamin D3) by 
HPLC-MS/MS. Remaining samples were analysed for fasting 
plasma glucose (FPG), fasting plasma insulin (FPI), and HbA1c 
at the  Diabetes Research Network Wales  Laboratory.  
Results:  
 
Significant negative correlations were observed between 
25(OH)D3 at 0 months and HbA1c at 12 months (r = -0.241, n = 
75, p = 0.04) and FPI at 12 months (r = -.225, n = 81, p = 0.04), 
but not FPG at 12 months (r = -.105, n = 80, p = 0.35).  
Conclusions: 
 
Vitamin D status only accounted for a small proportion of 
the variance (~5%) in the measures of glycaemia at 12 
months, however, the development of type 2 diabetes is 
multifactorial and any easily modifiable risk factors are 
noteworthy. A seasonal variation in vitamin D status  was 
observed for both FPG groups, and participants in the low 
FPG group had higher vitamin D concentrations than those 
in the high FPG group across the seasons. 
 
These findings may provide additional evidence of a 
protective effect of vitamin D in relation to glycaemic control 
and the development of type 2 diabetes, although, further 
studies are required to determine cause and effect. 
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Introduction 
 
There is emerging evidence linking vitamin D deficiency to 
impaired β-cell function, insulin resistance, and glucose 
intolerance, all of which are central to the pathogenesis of type 
2 diabetes1. 
When participants were separated based on FPG (group one 
≤ 6 mmol/l (n = 49) vs group 2 ≥ 6.1 mmol/l (n = 14)) a 2-way 
mixed ANOVA revealed a significant main effect of group on 
25(OH)D concentration (F(1,59) = 4.860, p < 0.05, partial n2 
= 0.076) and a main effect of time point (F(2,118) = 75.751, p 
< 0.05, partial n2 = 0.562). There was no statistically 
significant group × time interaction (F(2,118) = 0.680, p = 
0.51, partial n2 = 0.011)  
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(winter) and HbA1c at 12 months (winter).   
Figure 2: 25(OH)D concentration at the different time points 
in normal and high FPG groups (FPG ≤ 6 mmol/l vs ≥ 6.1 
mmol/l).  
